Human Gene SLA2 (ENST00000262866.9_10) from GENCODE V47lift37
  Description: Src like adaptor 2, transcript variant 1 (from RefSeq NM_032214.4)
Gencode Transcript: ENST00000262866.9_10
Gencode Gene: ENSG00000101082.14_12
Transcript (Including UTRs)
   Position: hg19 chr20:35,240,721-35,274,599 Size: 33,879 Total Exon Count: 8 Strand: -
Coding Region
   Position: hg19 chr20:35,242,269-35,269,738 Size: 27,470 Coding Exon Count: 7 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr20:35,240,721-35,274,599)mRNA (may differ from genome)Protein (261 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGeneCardsHGNC
MalacardsMGIOMIMPubMedUniProtKBWikipedia
BioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: SLAP2_HUMAN
DESCRIPTION: RecName: Full=Src-like-adapter 2; AltName: Full=Modulator of antigen receptor signaling; Short=MARS; AltName: Full=Src-like adapter protein 2; Short=SLAP-2;
FUNCTION: Adapter protein, which negatively regulates T-cell receptor (TCR) signaling. Inhibits T-cell antigen-receptor induced activation of nuclear factor of activated T-cells. May act by linking signaling proteins such as ZAP70 with CBL, leading to a CBL dependent degradation of signaling proteins.
SUBUNIT: Interacts (via SH2 domain) with ZAP70 (phosphorylated) and CD3Z (phosphorylated). Interacts (via SH2 domain) with CSF1R (phosphorylated) (By similarity). Interacts (via its C-terminal domain) with CBL (phosphorylated).
SUBCELLULAR LOCATION: Cytoplasm.
SUBCELLULAR LOCATION: Isoform 1: Cell membrane. Cytoplasmic vesicle. Note=Localized to the plasma membrane and intracellular vesicles, including late endosomal vesicles.
SUBCELLULAR LOCATION: Isoform 2: Cytoplasm (Probable). Note=May be cytoplasmic and is not localized to membranes.
TISSUE SPECIFICITY: Predominantly expressed in immune system, with highest levels in peripheral blood leukocytes. Expressed in spleen, thymus and lymph nodes. Expressed in T-cells as well as in monocytes, and at low level in B-cells. Also detected in placenta, prostate, skin, retina and colon.
DOMAIN: The loss of the C-terminal domain partially abolishes the inhibitory function, but can be partially compensated by higher level of protein expression.
PTM: Phosphorylated by CSF1R (By similarity).
SIMILARITY: Contains 1 SH2 domain.
SIMILARITY: Contains 1 SH3 domain.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: SLA2
Diseases sorted by gene-association score: cataract 8, multiple types (2)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 8.95 RPKM in Whole Blood
Total median expression: 25.13 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -143.90403-0.357 Picture PostScript Text
3' UTR -511.501548-0.330 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000980 - SH2
IPR001452 - SH3_domain

Pfam Domains:
PF00017 - SH2 domain
PF00018 - SH3 domain

SCOP Domains:
50044 - SH3-domain
55550 - SH2 domain

ModBase Predicted Comparative 3D Structure on Q9H6Q3
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004715 non-membrane spanning protein tyrosine kinase activity
GO:0005070 SH3/SH2 adaptor activity
GO:0005102 receptor binding
GO:0005515 protein binding
GO:0047485 protein N-terminus binding

Biological Process:
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0009966 regulation of signal transduction
GO:0009967 positive regulation of signal transduction
GO:0016477 cell migration
GO:0019724 B cell mediated immunity
GO:0030154 cell differentiation
GO:0030522 intracellular receptor signaling pathway
GO:0038083 peptidyl-tyrosine autophosphorylation
GO:0042110 T cell activation
GO:0042127 regulation of cell proliferation
GO:0045087 innate immune response
GO:0050776 regulation of immune response
GO:0050849 negative regulation of calcium-mediated signaling
GO:0050851 antigen receptor-mediated signaling pathway
GO:0050869 negative regulation of B cell activation

Cellular Component:
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005770 late endosome
GO:0005794 Golgi apparatus
GO:0005886 plasma membrane
GO:0010008 endosome membrane
GO:0016020 membrane
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane
GO:0031410 cytoplasmic vesicle
GO:0043231 intracellular membrane-bounded organelle


-  Descriptions from all associated GenBank mRNAs
  AK025645 - Homo sapiens cDNA: FLJ21992 fis, clone HEP06554.
BC042041 - Homo sapiens Src-like-adaptor 2, mRNA (cDNA clone MGC:49845 IMAGE:4429896), complete cds.
AK291513 - Homo sapiens cDNA FLJ78411 complete cds, highly similar to Homo sapiens Src-like-adaptor 2 (SLA2), transcript variant 1, mRNA.
AF290985 - Homo sapiens Src-like adaptor protein-2 mRNA, complete cds.
AF290986 - Homo sapiens Src-like adaptor protein-2 splice isoform mRNA, complete cds; alternatively spliced.
AF326353 - Homo sapiens Src-like adapter protein-2 mRNA, complete cds.
KJ894945 - Synthetic construct Homo sapiens clone ccsbBroadEn_04339 SLA2 gene, encodes complete protein.
AB527752 - Synthetic construct DNA, clone: pF1KB7957, Homo sapiens SLA2 gene for Src-like-adaptor 2, without stop codon, in Flexi system.
JD220529 - Sequence 201553 from Patent EP1572962.
JD279584 - Sequence 260608 from Patent EP1572962.
JD515315 - Sequence 496339 from Patent EP1572962.
JD520445 - Sequence 501469 from Patent EP1572962.
JD193092 - Sequence 174116 from Patent EP1572962.
JD383655 - Sequence 364679 from Patent EP1572962.
JD525086 - Sequence 506110 from Patent EP1572962.
JD099450 - Sequence 80474 from Patent EP1572962.
JD455314 - Sequence 436338 from Patent EP1572962.
JD120014 - Sequence 101038 from Patent EP1572962.
JD549034 - Sequence 530058 from Patent EP1572962.
JD238886 - Sequence 219910 from Patent EP1572962.
JD356643 - Sequence 337667 from Patent EP1572962.
JD328875 - Sequence 309899 from Patent EP1572962.
JD242595 - Sequence 223619 from Patent EP1572962.
JD333258 - Sequence 314282 from Patent EP1572962.
JD064088 - Sequence 45112 from Patent EP1572962.
JD505659 - Sequence 486683 from Patent EP1572962.
JD207647 - Sequence 188671 from Patent EP1572962.
JD072323 - Sequence 53347 from Patent EP1572962.
JD505658 - Sequence 486682 from Patent EP1572962.
JD313710 - Sequence 294734 from Patent EP1572962.
JD149078 - Sequence 130102 from Patent EP1572962.
JD132251 - Sequence 113275 from Patent EP1572962.
JD158418 - Sequence 139442 from Patent EP1572962.
JD207786 - Sequence 188810 from Patent EP1572962.
JD428409 - Sequence 409433 from Patent EP1572962.
JD393812 - Sequence 374836 from Patent EP1572962.
JD193001 - Sequence 174025 from Patent EP1572962.
JD271161 - Sequence 252185 from Patent EP1572962.
JD550383 - Sequence 531407 from Patent EP1572962.
JD428408 - Sequence 409432 from Patent EP1572962.
JD266140 - Sequence 247164 from Patent EP1572962.
JD113744 - Sequence 94768 from Patent EP1572962.
JD521194 - Sequence 502218 from Patent EP1572962.
JD389238 - Sequence 370262 from Patent EP1572962.
JD080294 - Sequence 61318 from Patent EP1572962.
JD319889 - Sequence 300913 from Patent EP1572962.
JD271094 - Sequence 252118 from Patent EP1572962.
JD223024 - Sequence 204048 from Patent EP1572962.
JD535104 - Sequence 516128 from Patent EP1572962.
JD145497 - Sequence 126521 from Patent EP1572962.
JD130530 - Sequence 111554 from Patent EP1572962.
JD508266 - Sequence 489290 from Patent EP1572962.
JD075581 - Sequence 56605 from Patent EP1572962.
JD256286 - Sequence 237310 from Patent EP1572962.
JD164868 - Sequence 145892 from Patent EP1572962.
JD467181 - Sequence 448205 from Patent EP1572962.
JD371133 - Sequence 352157 from Patent EP1572962.
JD410538 - Sequence 391562 from Patent EP1572962.
JD044236 - Sequence 25260 from Patent EP1572962.

-  Other Names for This Gene
  Alternate Gene Symbols: A8K648, C20orf156, E1P5U1, E1P5U2, ENST00000262866.1, ENST00000262866.2, ENST00000262866.3, ENST00000262866.4, ENST00000262866.5, ENST00000262866.6, ENST00000262866.7, ENST00000262866.8, NM_032214, Q5TH27, Q5TH28, Q8WY18, Q96QI4, Q9H135, Q9H6Q3, SLAP2, SLAP2_HUMAN, uc317hee.1, uc317hee.2
UCSC ID: ENST00000262866.9_10
RefSeq Accession: NM_032214.4
Protein: Q9H6Q3 (aka SLAP2_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.